Skip to content
1887

Abstract

The complete genome of West Nile (Sarafend) virus [WN(S)V] was sequenced. Phylogenetic trees utilizing the complete genomic sequence, capsid gene, envelope gene and NS5 gene/3′ untranslated region of WN(S)V classified WN(S)V as a lineage II virus. A full-length infectious clone of WN(S)V with a point mutation in the glycosylation site of the envelope protein (pWNS-S154A) was constructed. Both growth kinetics and the mode of maturation were affected by this mutation. The titre of the pWNS-S154A virus was lower than the wild-type virus. This defect was corrected by the expression of wild-type envelope protein in . The pWNS-S154A virus matured intracellularly instead of at the plasma membrane as shown for the parental WN(S)V.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81320-0
2006-03-01
2025-02-06
Loading full text...

Full text loading...

References

  1. Adams S. C., Broom A. K., Sammels L. M., Hartnett A. C., Howard M. J., Coelen R. J., Mackenzie J. S., Hall R. A. 1995; Glycosylation and antigenic variation among Kunjin virus isolates. Virology 206:49–56 [CrossRef]
    [Google Scholar]
  2. Bakonyi T., Hubalek Z., Rudolf I., Nowotny N. 2005; Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis 11:225–231 [CrossRef]
    [Google Scholar]
  3. Beasley D. W., Barrett A. D. 2002; Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76:13097–13100 [CrossRef]
    [Google Scholar]
  4. Beasley D. W., Li L., Suderman M. T., Barrett A. D. 2002; Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17–23 [CrossRef]
    [Google Scholar]
  5. Berthet F. X., Zeller H. G., Drouet M. T., Rauzier J., Digoutte J. P., Deubel V. 1997; Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol 78:2293–2297
    [Google Scholar]
  6. Bhuvanakantham R., Ng M. L. 2005; Analysis of self-association of West Nile virus capsid protein and the crucial role played by Trp 69 in homodimerization. Biochem Biophys Res Commun 329:246–255 [CrossRef]
    [Google Scholar]
  7. Brandt M., Yao K., Liu M., Heckert R. A., Vakharia V. N. 2001; Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J Virol 75:11974–11982 [CrossRef]
    [Google Scholar]
  8. Bressanelli S., Stiasny K., Allison S. L., Stura E. A., Duquerroy S., Lescar J., Heinz F. X., Rey F. A. 2004; Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23:728–738 [CrossRef]
    [Google Scholar]
  9. Chambers T. J., Hahn C. S., Galler R., Rice C. M. 1990; Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649–688 [CrossRef]
    [Google Scholar]
  10. Chambers T. J., Halevy M., Nestorowicz A., Rice C. M., Lustig S. 1998; West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol 79:2375–2380
    [Google Scholar]
  11. Halevy M., Akov Y., Ben-Nathan D., Kobiler D., Lachmi B., Lustig S. 1994; Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137:355–370 [CrossRef]
    [Google Scholar]
  12. Hase T. 1993; Virus-neuron interactions in the mouse brain infected with Japanese encephalitis virus. Virchows Arch B Cell Pathol Incl Mol Pathol 64:161–170 [CrossRef]
    [Google Scholar]
  13. Hase T., Summers P. L., Eckels K. H., Baze W. B. 1987a; Maturation process of Japanese encephalitis virus in cultured mosquito cells in vivo and mouse brain cells in vivo . Arch Virol 96:135–151 [CrossRef]
    [Google Scholar]
  14. Hase T., Summers P. L., Eckels K. H., Baze W. B. 1987b; An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: maturation events. Arch Virol 92:273–291 [CrossRef]
    [Google Scholar]
  15. Heinz F. X. 1986; Epitope mapping of flavivirus glycoproteins. Adv Virus Res 31:103–168
    [Google Scholar]
  16. Ishak H., Takegami T., Kamimura K., Funada H. 2001; Comparative sequences of two type 1 dengue virus strains possessing different growth characteristics in vivo . Microbiol Immunol 45:327–331 [CrossRef]
    [Google Scholar]
  17. Johnson A. J., Guirakhoo F., Roehrig J. T. 1994; The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203:241–249 [CrossRef]
    [Google Scholar]
  18. Lad V. J., Shende V. R., Gupta A. K., Koshy A. A., Roy A. 2000; Effect of tunicamycin on expression of epitopes on Japanese encephalitis virus glycoprotein E in porcine kidney cells. Acta Virol 44:359–364
    [Google Scholar]
  19. Lanciotti R. S., Ebel G. D., Deubel V. & 9 other authors 2002; Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298:96–105 [CrossRef]
    [Google Scholar]
  20. Li J., Bhuvanakantham R., Howe J., Ng M. L. 2005a; Identifying the region influencing the cis -mode of maturation of West Nile (Sarafend) virus using chimeric infectious clones. Biochem Biophys Res Commun 334:714–720 [CrossRef]
    [Google Scholar]
  21. Li L., Barrett A. D., Beasley D. W. 2005b; Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335:99–105 [CrossRef]
    [Google Scholar]
  22. Lobigs M., Dalgarno L., Schlesinger J. J., Weir R. C. 1987; Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain). Virology 161:474–478 [CrossRef]
    [Google Scholar]
  23. Lorenz I. C., Kartenbeck J., Mezzacasa A., Allison S. L., Heinz F. X., Helenius A. 2003; Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol 77:4370–4382 [CrossRef]
    [Google Scholar]
  24. McMinn P. C., Lee E., Hartley S., Roehrig J. T., Dalgarno L., Weir R. C. 1995; Murray Valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology 211:10–20 [CrossRef]
    [Google Scholar]
  25. Modis Y., Ogata S., Clements D., Harrison S. C. 2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991 [CrossRef]
    [Google Scholar]
  26. Mukhopadhyay S., Kim B. S., Chipman P. R., Rossmann M. G., Kuhn R. J. 2003; Structure of West Nile virus. Science 302:248 [CrossRef]
    [Google Scholar]
  27. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J. L., Arenzana-Seisdedos F., Despres P. 2003; Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723–728 [CrossRef]
    [Google Scholar]
  28. Ng M. L. 1987; Ultrastructural studies of Kunjin virus-infected Aedes albopictus cells. J Gen Virol 68:577–582 [CrossRef]
    [Google Scholar]
  29. Ng M. L., Howe J., Sreenivasan V., Mulders J. J. 1994; Flavivirus West Nile (Sarafend) egress at the plasma membrane. Arch Virol 137:303–313 [CrossRef]
    [Google Scholar]
  30. Oliphant T., Engle M., Nybakken G. E. & 11 other authors 2005; Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11:522–530 [CrossRef]
    [Google Scholar]
  31. Pletnev A. G., Bray M., Lai C. J. 1993; Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol 67:4956–4963
    [Google Scholar]
  32. Rahman S., Matsumura T., Masuda K., Kanemura K., Fukunaga T. 1998; Maturation site of dengue type 2 virus in cultured mosquito C6/36 cells and Vero cells. Kobe J Med Sci 44:65–79
    [Google Scholar]
  33. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. 1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298 [CrossRef]
    [Google Scholar]
  34. Ryman K. D., Ledger T. N., Weir R. C., Schlesinger J. J., Barrett A. D. 1997; Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J Gen Virol 78:1353–1356
    [Google Scholar]
  35. Sanchez M. D., Pierson T. C., McAllister D., Hanna S. L., Puffer B. A., Valentine L. E., Murtadha M. M., Hoxie J. A., Doms R. W. 2005; Characterization of neutralizing antibodies to West Nile virus. Virology 336:70–82 [CrossRef]
    [Google Scholar]
  36. Scherret J. H., Poidinger M., Mackenzie J. S., Broom A. K., Deubel V., Lipkin W. I., Briese T., Gould E. A., Hall R. A. 2001a; The relationships between West Nile and Kunjin viruses. Emerg Infect Dis 7:697–705 [CrossRef]
    [Google Scholar]
  37. Scherret J. H., Mackenzie J. S., Khromykh A. A., Hall R. A. 2001b; Biological significance of glycosylation of the envelope protein of Kunjin virus. Ann N Y Acad Sci 951:361–363
    [Google Scholar]
  38. Scherret J. H., Mackenzie J. S., Hall R. A., Deubel V., Gould E. A. 2002; Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. Curr Top Microbiol Immunol 267:373–390
    [Google Scholar]
  39. Serafino A., Valli M. B., Alessandrini A., Ponzetto A., Carloni G., Bertolini L. 1997; Ultrastructural observations of viral particles within hepatitis C virus-infected human B lymphoblastoid cell line. Res Virol 148:153–159 [CrossRef]
    [Google Scholar]
  40. Shi P. Y., Tilgner M., Lo M. K., Kent K. A., Bernard K. A. 2002; Infectious cDNA clone of the epidemic West Nile virus from New York City. J Virol 76:5847–5856 [CrossRef]
    [Google Scholar]
  41. Shirato K., Miyoshi H., Goto A., Ako Y., Ueki T., Kariwa H., Takashima I. 2004; Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol 85:3637–3645 [CrossRef]
    [Google Scholar]
  42. Sreenivasan V., Ng K. L., Ng M. L. 1993; Brefeldin A affects West Nile virus replication in Vero cells but not C6/36 cells. J Virol Methods 45:1–17 [CrossRef]
    [Google Scholar]
  43. Vorndam V., Mathews J. H., Barrett A. D., Roehrig J. T., Trent D. W. 1993; Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol 74:2653–2660 [CrossRef]
    [Google Scholar]
  44. Wang Y., Lobigs M., Lee E., Mullbacher A. 2003; CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77:13323–13334 [CrossRef]
    [Google Scholar]
  45. Westaway E. G., Brinton M. A., Gaidamovich S. & 7 other authors 1985; Flaviviridae . Intervirology24183–192 [CrossRef]
    [Google Scholar]
  46. Whealy M. E., Card J. P., Meade R. P., Robbins A. K., Enquist L. W. 1991; Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol 65:1066–1081
    [Google Scholar]
  47. Zhang W., Chipman P. R., Corver J. & 7 other authors 2003; Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10:907–912 [CrossRef]
    [Google Scholar]
  48. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J. H., Baker T. S., Kuhn R. J., Rossmann M. G. 2004; Conformational changes of the flavivirus E glycoprotein. Structure 12:1607–1618 [CrossRef]
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.81320-0
Loading
/content/journal/jgv/10.1099/vir.0.81320-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error